|
1
|
Rinella ME: Nonalcoholic fatty liver
disease: a systematic review. JAMA. 313:2263–2273. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Targher G, Chonchol MB and Byrne CD: CKD
and nonalcoholic fatty liver disease. Am J Kidney Dis. 64:638–652.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Granér M, Nyman K, Siren R, Pentikäinen
MO, Lundbom J, Hakkarainen A, Lauerma K, Lundbom N, Nieminen MS and
Taskinen MR: Ectopic fat depots and left ventricular function in
nondiabetic men with nonalcoholic fatty liver disease. Circ
Cardiovasc Imaging. 8:e0019792015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fargion S, Porzio M and Fracanzani AL:
Nonalcoholic fatty liver disease and vascular disease:
state-of-the-art. World J Gastroenterol. 20:13306–13324. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu H, Jin M, Han D, Zhou M, Mei X, Guan Y
and Liu C: Protective effects of aerobic swimming training on
high-fat diet induced nonalcoholic fatty liver disease: Regulation
of lipid metabolism via PANDER-AKT pathway. Biochem Biophys Res
Commun. 458:862–868. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Paradies G, Paradies V, Ruggiero FM and
Petrosillo G: Oxidative stress, cardiolipin and mitochondrial
dysfunction in nonalcoholic fatty liver disease. World J
Gastroenterol. 20:14205–14218. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Haap M, Machann J, von Friedeburg C,
Schick F, Stefan N, Schwenzer NF, Fritsche A, Häring HU and Thamer
C: Insulin sensitivity and liver fat: role of iron load. J Clin
Endocrinol Metab. 96:E958–E961. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao CY, Yan L, Wang YD, Wang W, Zhou JY
and Zhen Z: Role of resistin in inflammation of hepatocytes in
nonalcoholic steatohepatitis. Zhonghua Gan Zang Bing Za Zhi.
17:683–687. 2009.(In Chinese). PubMed/NCBI
|
|
9
|
Rivera CA, Adegboyega P, van Rooijen N,
Tagalicud A, Allman M and Wallace M: Toll-like receptor-4 signaling
and Kupffer cells play pivotal roles in the pathogenesis of
non-alcoholic steatohepatitis. J Hepatol. 47:571–579. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aboul-Enein A, El-Beshlawy A, Hamdy M,
Shaheen I, El-Saadany Z, Samir A and El-Samie HA: Peripheral
expression of hepcidin gene in Egyptian β-thalassemia major. Gene.
564:206–209. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Boumaiza M, Ezzine A, Jaouen M, Sari MA
and Marzouki MN: Molecular characterization of a novel hepcidin
(HepcD) from Camelus dromedarius. Synthetic peptide forms
exhibit antibacterial activity. J Pept Sci. 20:680–688. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ganz T: Hepcidin and iron regulation, 10
years later. Blood. 117:4425–4433. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mitsuyoshi H, Yasui K, Harano Y, Endo M,
Tsuji K, Minami M, Itoh Y, Okanoue T and Yoshikawa T: Analysis of
hepatic genes involved in the metabolism of fatty acids and iron in
nonalcoholic fatty liver disease. Hepatol Res. 39:366–373. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tsuchiya H, Ashla AA, Hoshikawa Y, Matsumi
Y, Kanki K, Enjoji M, Momosaki S, Nakamuta M, Taketomi A, Maehara
Y, et al: Iron state in association with retinoid metabolism in
non-alcoholic fatty liver disease. Hepatol Res. 40:1227–1238. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Csak T, Ganz M, Pespisa J, Kodys K,
Dolganiuc A and Szabo G: Fatty acid and endotoxin activate
inflammasomes in mouse hepatocytes that release danger signals to
stimulate immune cells. Hepatology. 54:133–144. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Amacher DE: Progress in the search for
circulating biomarkers of nonalcoholic fatty liver disease.
Biomarkers. 19:541–552. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hassan K, Bhalla V, El Regal ME and
A-Kader HH: Nonalcoholic fatty liver disease: a comprehensive
review of a growing epidemic. World J Gastroenterol.
20:12082–12101. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wynn TA: Cellular and molecular mechanisms
of fibrosis. J Pathol. 214:199–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kelley CE, Brown AJ, Diehl AM and Setji
TL: Review of nonalcoholic fatty liver disease in women with
polycystic ovary syndrome. World J Gastroenterol. 20:14172–14184.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fitzpatrick E and Dhawan A: Noninvasive
biomarkers in non-alcoholic fatty liver disease: current status and
a glimpse of the future. World J Gastroenterol. 20:10851–10863.
2014. View Article : Google Scholar : PubMed/NCBI
|
